Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
other information
Study period:
Nov to Dec 2000
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: well reported Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2001
Report date:
2001

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
yes
Remarks:
3 instead of 5 animals/sex used according to acute-toxic-class-method (OECD 423)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
17 beta-Hydroxy-17 alpha-(3-hydroxy-1-propynyl)-4-androsten-3-one
IUPAC Name:
17 beta-Hydroxy-17 alpha-(3-hydroxy-1-propynyl)-4-androsten-3-one
Details on test material:
- Name of test material (as cited in study report): ZK 4829
- Batch No: 59002501

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
physiological saline
Duration of exposure:
24 hours
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.

Any other information on results incl. tables

No mortalities occurred. Reddened nose was observed in all animals at 1 hour after substance administration and in one of the three male animals and in two of the three female animals at 3 hours after substance administration. All animals were without clinical findings from the second day after treatment onwards. The body weight of one male decreased between day 1 and day 8 of the study. From day 8 to day 15 body weight gain was, compared to the other male animals, only slightly lower. As all other animals did not show this effect, the significance of the finding remains unclear. No compound-related findings were observed at necropsy. Moreover, no compound-related local findings were observed. The mean values of findings at the time-points 1, 24, 48 and 72 h after administration were 0 for swelling, reddening and scab formation.

Applicant's summary and conclusion

Executive summary:

The single dermal administration of the test substance (ZK 4829) to male and female rats at a dose of 2000 mg/kg was tolerated without any mortality. Reddened nose was observed in all animals at 1 hour after substance administration and in one of the three male animals and in two of the three female animals at 3 hours after substance administration. All animals were without clinical findings from the second day after treatment onwards. The body weight of one male decreased between day 1 and day 8 of the study. From day 8 to day 15 body weight gain was, compared to the other male animals, only slightly lower. As all other animals did not show this effect, the significance of the finding remains unclear. No compound-related findings were observed at necropsy.

The acute dermal toxicity of Hydroxypropinol in rats is therefore above 2000 mg/kg body weight.

Moreover, no compound-related local findings were observed. The mean values of findings at the time-points 1, 24, 48 and 72 h after administration were 0 for swelling, reddening and scab formation.